Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Get Free Report) was the target of a significant decrease in short interest during the month of October. As of October 30th, there was short interest totaling 23,659 shares, a decrease of 64.2% from the October 15th total of 66,171 shares. Based on an average trading volume of 52,754 shares, the short-interest ratio is currently 0.4 days. Currently, 0.2% of the company’s shares are sold short.
Institutional Trading of Columbia Research Enhanced Value ETF
Several institutional investors have recently made changes to their positions in REVS. Ruggaard & Associates LLC boosted its holdings in shares of Columbia Research Enhanced Value ETF by 0.6% in the first quarter. Ruggaard & Associates LLC now owns 52,425 shares of the company’s stock worth $1,500,000 after acquiring an additional 322 shares during the period. CoreCap Advisors LLC purchased a new stake in Columbia Research Enhanced Value ETF during the 3rd quarter valued at $30,000. Western Wealth Management LLC purchased a new stake in Columbia Research Enhanced Value ETF in the first quarter worth $29,000. Farther Finance Advisors LLC bought a new position in shares of Columbia Research Enhanced Value ETF in the 3rd quarter worth approximately $40,000. Finally, Harbour Investments Inc. bought a new stake in Columbia Research Enhanced Value ETF during the third quarter worth about $86,000.
Columbia Research Enhanced Value ETF Trading Down 0.7%
NYSEARCA REVS traded down $0.25 on Monday, hitting $34.49. 34,346 shares of the company were exchanged, compared to its average volume of 50,081. Columbia Research Enhanced Value ETF has a 12 month low of $27.24 and a 12 month high of $35.44. The stock has a fifty day moving average of $33.84 and a 200-day moving average of $31.79. The company has a market cap of $403.53 million, a PE ratio of 18.11 and a beta of 0.79.
Columbia Research Enhanced Value ETF Company Profile
The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.
Featured Stories
- Five stocks we like better than Columbia Research Enhanced Value ETF
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
